ACETO Corporation Schedules Second Quarter Fiscal 2015 Financial Results News Release and Conference Call
27 January 2015 - 1:29AM
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing,
sale and distribution of products for Human Health, Pharmaceutical
Ingredients and Performance Chemicals, will issue its financial
results of operations for the second quarter of fiscal 2015 ended
December 31, 2014 after the stock market close on Thursday,
February 5, 2015.
Management will host a conference call to discuss the operating
and financial results at 9:00am EST on Friday, February 6, 2015. To
participate in the conference call, please dial (888) 895-5271 or
(847) 619-6547 approximately 10 minutes prior to the call. Please
reference conference ID # 38818311.
A live webcast of the conference call will be available in the
Investor Relations section of the Company's website, www.aceto.com.
Please access the website 15 minutes prior to the start of the call
to download and install any necessary audio software.
A telephone replay of the conference call will be available from
11:30 a.m. EST on February 6, 2015 until 11:59 p.m. EST on February
13, 2015 and may be accessed by calling (888) 843-7419 and
reference conference ID # 38818311. An archived replay of the
conference call will also be available in the investor relations
section of the Company's website.
ABOUT ACETO
ACETO Corporation, incorporated in 1947, is a global leader in
the marketing, sale and distribution of products for Human Health
(finished dosage form generics and nutraceutical products),
Pharmaceutical Ingredients (pharmaceutical intermediates and active
pharmaceutical ingredients) and Performance Chemicals (specialty
chemicals and agricultural protection products). With business
operations in nine countries, ACETO distributes over 1,100 chemical
compounds used principally as finished products or raw materials in
the pharmaceutical, nutraceutical, agricultural, coatings and
industrial chemical industries. ACETO's global operations,
including a staff of 25 in China and 12 in India, are distinctive
in the industry and enable its worldwide sourcing and regulatory
capabilities.
CONTACT: Investor Relations Contact:
LHA
Jody Burfening
jburfening@lhai.com
(212) 838-3777